Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vasomotor Symptoms (VMS)”

26 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26 results

Not applicableStudy completedNCT05300568
What this trial is testing

A Survey About Trade-offs When Choosing Menopause Treatments

Who this might be right for
Moderate to Severe Vasomotor Symptoms
Astellas Pharma Europe Ltd. 1,465
Not applicableLooking for participantsNCT07602530
What this trial is testing

A Study in Canada to Follow Outcomes of Women in Menopause Treated With Fezolinetant for Hot Flashes, When Given in Clinical Practice

Who this might be right for
Hot Flashes
Astellas Pharma Europe Ltd. 238
Not applicableStudy completedNCT07408115
What this trial is testing

Herbal Dietary Supplementation on Vasomotor Symptoms in Menopausal Women

Who this might be right for
Hot FlashesHot FlashHot Flushes, Menopause, Postmenopause+6 more
Bonafide Health 112
Not applicableEnrolling By InvitationNCT07511660
What this trial is testing

Intra Ovarian Muse Cell Injection for Perimenopause Symptom Relief and Ovarian Function Restoration (MUSE-OVARY)

Who this might be right for
PerimenopausePerimenopause-Related DepressionPremature Ovarian Insufficiency+19 more
Healing Hope International 12
Not applicableEnded earlyNCT01353963
What this trial is testing

Desvenlafaxine Succinate (Pristiq): Postmarketing Surveillance Study Among Filipino Patients

Who this might be right for
Major Depressive DisorderVasomotor Symptoms
Pfizer 13
Not applicableLooking for participantsNCT07535541
What this trial is testing

A Feasibility Study of Biometric Measurements Via Wearable Smart Watch Technology for Evaluation of Vasomotor Symptoms in Patients Treated With Androgen Deprivation Therapy for Prostate Cancer (Prostate 007)

Who this might be right for
Prostate CancerHot Flashes
University of Virginia 18
Not applicableLooking for participantsNCT06949553
What this trial is testing

An Observational Study to Learn More About Vasomotor Symptoms Burden and Treatment Patterns in Menopausal Women Before and After Participating in OASIS Studies

Who this might be right for
Vasomotor Symptoms (VMS) Associated With Menopause
Bayer 250
Post-approval studies (Phase 4)Study completedNCT00195455
What this trial is testing

Study Evaluating Estradiol/Trimegestone in Vasomotor Symptoms (VMS) in Post-Menopausal Women.

Who this might be right for
Postmenopause
Wyeth is now a wholly owned subsidiary of Pfizer 133
Testing effectiveness (Phase 2)Study completedNCT03518138
What this trial is testing

Safety/Efficacy of Q-122 in Breast Cancer Patients Taking Tamoxifen or Aromatase Inhibitor

Who this might be right for
Vasomotor Symptoms (VMS)
Que Oncology 132
Not applicableUnknownNCT06289907
What this trial is testing

Hot Flash and Night Sweat Virtual Study

Who this might be right for
Menopause
Bonafide Health 80
Testing effectiveness (Phase 2)Ended earlyNCT06161792
What this trial is testing

Evaluate RCN3028 in Treatment of Drug-Induced VMS in Breast Cancer

Who this might be right for
Hot FlashesBreast Cancer
Yung Shin Pharm. Ind. Co., Ltd. 10
Large-scale testing (Phase 3)Study completedNCT01361308
What this trial is testing

Efficacy/Safety Study of Brisdelle™ (Formerly Known as Mesafem) in the Treatment of Vasomotor Symptoms (VMS)

Who this might be right for
Postmenopausal Symptoms
Noven Therapeutics 614
Testing effectiveness (Phase 2)Looking for participantsNCT06957691
What this trial is testing

Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy

Who this might be right for
Prostate CancerProstate Cancer (Adenocarcinoma)Prostate Cancer Metastatic Disease+16 more
Shehzad Basaria, M.D. 60
Not applicableLooking for participantsNCT06976112
What this trial is testing

Impact of Lean Pork on Endothelial Function in Perimenopause

Who this might be right for
Cardiovascular OutcomeOverweight and Obese WomenPerimenopausal Women+1 more
Pennington Biomedical Research Center 30
Testing effectiveness (Phase 2)Study completedNCT03541200
What this trial is testing

Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms

Who this might be right for
Vasomotor Symptoms (VMS)
Tanabe Pharma America, Inc. 190
Not applicableLooking for participantsNCT07033013
What this trial is testing

A Randomized, Double Blind, Placebo Controlled, Clinical Study to Examine the Benefits of an Oral Product in Panelists With Menopausal Symptoms Including Vasomotor Symptoms (VMS).

Who this might be right for
Healthy
Olly, PBC 40
Not applicableNot Yet RecruitingNCT07490431
What this trial is testing

An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Symptoms in United States

Who this might be right for
Vasomotor Symptoms (VMS) Associated With Menopause
Bayer 1,500
Large-scale testing (Phase 3)Study completedNCT04451226
What this trial is testing

Assess the Safety and Tolerability of Fezolinetant in Women Seeking Treatment for Relief of Vasomotor Symptoms (VMS) Associated With Menopause

Who this might be right for
Hot Flashes
Astellas Pharma China, Inc. 150
Testing effectiveness (Phase 2)Study completedNCT05325775
What this trial is testing

Dose-ranging, PK, Safety, Efficacy Study of Osanetant in Patients With Moderate/Severe VMS Associated With Menopause

Who this might be right for
Post-menopausal Vasomotor Symptoms
Acer Therapeutics Inc. 49
Early research (Phase 1)Study completedNCT04080297
What this trial is testing

Dose Escalation Study in Female Subjects With Breast Cancer Receiving Aromatase Inhibitor or Tamoxifen

Who this might be right for
Vasomotor Symptoms (VMS)
Que Oncology 21
Load More Results